BioNanomatrix
Philadelphia-based BioNanomatrix is developing nanoscale single-molecule technology that will enable identification and analysis of an entire genome.
The firm recently formed a joint venture with Complete Genomics to use an $8.8 million grant from the US National Institute of Standards and Technology to develop a platform aimed at sequencing a human genome in eight hours for under $100.
[November 5, 2007] Agilent Technologies and BioNanomatrix team to develop an integrated genetic analysis system with applications in genotoxicity and cytogenetics assay development, and potentially DNA sequencing. Under the agreement, the companies plan to combine BioNanomatrix’s single-molecule imaging technology to develop chips and reagents with a measurement platform developed by Agilent.